BioMed Research International / 2017 / Article / Fig 3

Research Article

The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China

Figure 3

Comparison of the positive rates of Xpert in different samples. GraphPad Prism 5.03 (GraphPad Software Inc., San Diego, CA, USA) was used to generate the figure. indicated .

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.